Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

被引:1
|
作者
van Doeveren, Thomas
Remmers, Sebastiaan
van den Bergh, Roderick C. N.
Boeve, Egbert R. [1 ]
Atema, Vera [1 ]
Cornel, Erik B. [2 ]
van der Heijden, Antoine G. [3 ]
Hendricksen, Kees [4 ]
Cauberg, Evelyne C. C. [5 ]
Jacobs, Rens A. L. [6 ]
Kroon, Bin K. [7 ]
Leliveld, Annemarie M. [8 ]
Meijer, Richard P. [9 ]
Merks, Bob [10 ]
Oddens, Jorg R. [11 ]
Roelofs, Luc [12 ]
Somford, Diederik M. [14 ]
de Vries, Peter [13 ]
Wijsman, Bart [15 ]
Windt, Willemijn A. K. M. [16 ]
Zwaan, Peter J. [17 ]
van Leeuwen, Pim J. [5 ]
Boormans, Joost L.
Aben, Katja K. H. [18 ,19 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Urol, Rotterdam, Netherlands
[2] Netherlands Comprehens Canc Org, Dept Res & Dev, Utrecht, Netherlands
[3] St Antonius Hosp, Nieuwegein, Netherlands
[4] Franciscus Gasthuis & Vlietland, Dept Urol, Rotterdam, Netherlands
[5] Ziekenhuis Grp Twente, Dept Urol, Almelo, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands
[7] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[8] Isala Oncol Ctr, Dept Med Oncol, Zwolle, Netherlands
[9] Zuyderland Med Ctr, Dept Pulmonol, Heerlen Sittard, Netherlands
[10] Rijnstate Med Ctr, Dept Immunol, Arnhem, Netherlands
[11] Univ Med Ctr Groningen, Dept Urol, Groningen, Netherlands
[12] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands
[13] Haaglanden Med Ctr, Dept Pulmonol, Leidschendam, Netherlands
[14] Univ Amsterdam, AmsterdamUMC, Amsterdam, Netherlands
[15] Treant Zorggroep, Dept Cardiol, Emmen, Netherlands
[16] Canisius Wilhelmina Ziekenhuis, Dept Urol, Nijmegen, Netherlands
[17] Elisabeth TweeSteden Hosp, Dept Gynecol & Obstet, Tilburg, Netherlands
[18] Martini Ziekenhuis, Groningen, Netherlands
[19] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands
来源
关键词
European Organisation for; Research and Treatment of; Cancer Quality of Life; Questionnaire C30; Health-related quality of life; Radical surgery; Short term; Upper urinary tract; Urothelial carcinoma; SHARED DECISION-MAKING; EUROPEAN-ORGANIZATION; CANCER; ANXIETY; COMPLICATIONS; DEPRESSION; GENDER;
D O I
10.1016/j.euros.2023.12.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The possible negative impact of radical surgery on patients' health -related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary tract urothelial carcinoma (UTUC) in the context of a single -arm phase 2 multicenter study, in which the safety and efficacy of a single preoperative intravesical instillation with mitomycin C were investigated. Our objective was to investigate early changes in HRQoL in patients undergoing radical surgery for UTUC and identify factors associated with these outcomes. Methods: Patients with pTanyN0-1M0 UTUC were prospectively included. HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire at baseline, and at 1 and 3 mo after surgery. A linear mixed model was used to evaluate the changes in HRQoL over time and identify the variables associated with these outcomes. The clinical effect size was used to assess the clinical impact and level of perceptibility of HRQoL changes for clinicians and/or patients based on given thresholds. Key findings and limitations: Between 2017 and 2020, 186 patients were included. At baseline, 1 mo after surgery, and 3 mo after surgery, response rates were 91%, 84%, and 78%, respectively. One month after surgery, a statistically significant and clinically relevant deterioration was observed in physical, role, and social functioning, and for the included symptom scales: constipation, fatigue, and pain. An improvement in emotional functioning was observed. At 3 mo, HRQoL returned to baseline levels, except emotional functioning, which improved at 1 mo and persisted to be better than that before surgery. Age >70 yr was associated with worse physical functioning, but better social and emotional functioning. Male patients reported better emotional functioning than females. Postoperative complications were negatively associated with social functioning. Conclusions and clinical implications: UTUC patients treated with radical surgery experienced a significant, albeit temporary, decline in HRQoL. Three months following surgery, HRQoL outcomes returned to baseline levels. This information can be used to counsel UTUC patients before undergoing radical surgery and contextualize recovery after surgery. Patient summary: We investigated the changes in quality of life as reported by patients who underwent surgery for upper tract urothelial carcinoma (UTUC). We found that patients experienced a decline in quality of life 1 mo after surgery, but this was temporary, with full recovery of quality of life 3 mo after surgery. These findings can help doctors and other medical staff in counseling UTUC patients before undergoing radical surgery. (c) 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [31] Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial
    Feldman, SR
    Kimball, AB
    Krueger, GG
    Woolley, JM
    Lalla, D
    Jahreis, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (05) : 887 - 889
  • [32] Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival
    Schneidewind, Laila
    Draeger, Desiree Louise
    Rossberg, Vanessa
    Nolting, Julia
    Hakenberg, Oliver W.
    UROLOGIA INTERNATIONALIS, 2023, 107 (01) : 80 - 86
  • [33] Health-related quality of life with Garadacimab for hereditary angioedema prophylaxis: Results from a Phase 2 trial
    Aygoeren-Puersuen, E.
    Lumry, W. R.
    Saguer, I. Martinez
    Jacobs, J. S.
    Yang, W. H.
    Keith, P. K.
    Busse, P.
    Reshef, A.
    Craig, T. J.
    Lawo, J. P.
    Kormann, D.
    Pragst, I.
    Magerl, M.
    ALLERGOLOGIE, 2023, 46 (08) : 563 - 563
  • [34] Health-related quality of life became worse in short-term during treatment in head and neck cancer patients: a prospective study
    do Nascimento Santos Lima, Emanuelle
    Ferreira, Isabela Borges
    Lajolo, Paula Philbert
    Paiva, Carlos Eduardo
    de Paiva Maia, Yara Cristina
    das Gracas Pena, Georgia
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [35] Health-related quality of life became worse in short-term during treatment in head and neck cancer patients: a prospective study
    Emanuelle do Nascimento Santos Lima
    Isabela Borges Ferreira
    Paula Philbert Lajolo
    Carlos Eduardo Paiva
    Yara Cristina de Paiva Maia
    Geórgia das Graças Pena
    Health and Quality of Life Outcomes, 18
  • [36] Effect of Perioperative Palliative Care on Health-Related Quality of Life Among Patients Undergoing Surgery for Cancer: A Randomized Clinical Trial
    Aslakson, Rebecca A.
    Rickerson, Elizabeth
    Fahy, Bridget
    Waterman, Brittany
    Siden, Rachel
    Colborn, Kathryn
    Smith, Shelby
    Verano, Mae
    Lira, Isaac
    Hollahan, Caroline
    Siddiqi, Amn
    Johnson, Kemba
    Chandrashekaran, Shivani
    Harris, Elizabeth
    Nudotor, Richard
    Baker, Joshua
    Heidari, Shireen N.
    Poultsides, George
    Conca-Cheng, Alison M.
    Chapman, Allyson Cook
    Lessios, Anna Sophia
    Holdsworth, Laura M.
    Gustin, Jillian
    Ejaz, Aslam
    Pawlik, Timothy
    Miller, Judi
    Morris, Arden M.
    Tulsky, James A.
    Lorenz, Karl
    Temel, Jennifer S.
    Smith, Thomas J.
    Johnston, Fabian
    JAMA NETWORK OPEN, 2023, 6 (05)
  • [37] Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial
    Witjes, Johannes Alfred
    Galsky, Matthew D.
    Gschwend, Juergen E.
    Broughton, Edward
    Braverman, Julia
    Nasroulah, Federico
    Maira-Arce, Mario
    Ye, Xiaomei
    Shi, Ling
    Guo, Shien
    Hamilton, Melissa
    Bajorin, Dean F.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 553 - 563
  • [38] Dupilumab improves health-related quality of life and absenteeism in nasal polyposis patients: results from a phase 2a trial
    Bachert, C.
    Hellings, P.
    Mullol, J.
    Hamilos, D.
    Naclerio, R.
    Joish, V. N.
    Mannent, L.
    Evans, R.
    Abbe, A.
    Amand, C.
    Taniou, C.
    Zhang, D.
    Fan, C.
    Pirozzi, G.
    Graham, N.
    Mastey, V
    Mahajan, S.
    Staudinger, H.
    Eckert, L.
    Khan, A.
    ALLERGY, 2016, 71 : 12 - 12
  • [39] Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept
    David Lin
    Allan Klein
    David Cella
    Anna Beutler
    Fang Fang
    Matt Magestro
    Paul Cremer
    Martin M. LeWinter
    Sushil Allen Luis
    Antonio Abbate
    Andrew Ertel
    Leighann Litcher-Kelly
    Brittany Klooster
    John F. Paolini
    BMC Cardiovascular Disorders, 21
  • [40] Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept
    Lin, David
    Klein, Allan
    Cella, David
    Beutler, Anna
    Fang, Fang
    Magestro, Matt
    Cremer, Paul
    LeWinter, Martin M.
    Luis, Sushil Allen
    Abbate, Antonio
    Ertel, Andrew
    Litcher-Kelly, Leighann
    Klooster, Brittany
    Paolini, John F.
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)